Author Archives: Chandra Ganegoda

BriaCell Partners with Waisman Biomanufacturing to Manufacture and Supply Prostate Cancer Immunotherapy
July 5, 2022

Extended survival and tumor shrinkage in advanced breast cancer patients who matched the immunotherapy HLA ...

BriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment
June 29, 2022

PHILADELPHIA and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal
June 24, 2022

Anti-Cancer activity of BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer patients was published in ...

BriaCell Adds Additional Clinical Sites to Broaden Patient Access and Further Boost Enrollment
May 18, 2022

PHILADELPHIA and VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
April 13, 2022

U.S. Food and Drug Administration (FDA) has granted Fast Track status to BriaCell’s lead candidate, ...

BriaCell Presents Development Details of Bria-OTS(TM) Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022
April 12, 2022

Based on clinical data with Bria-IMT™, BriaCell has developed Bria-OTS™, an off-the-shelf (i.e. pre-manufactured) personalized ...

BriaCell advances preparatory work for new Bria-OTS(TM) breast cancer clinical trial
April 7, 2022

Bria-OTS™ would build on BriaCell’s existing clinical trial data with Bria-IMT™, treating each patient with ...

BriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollment
February 28, 2022

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board
February 23, 2022

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer
February 16, 2022

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

Skip to content